<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Sam Barrett on Medium]]></title>
        <description><![CDATA[Stories by Sam Barrett on Medium]]></description>
        <link>https://medium.com/@scbarrett?source=rss-462a689e2597------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*uzT_sfakpXI2b2j2.</url>
            <title>Stories by Sam Barrett on Medium</title>
            <link>https://medium.com/@scbarrett?source=rss-462a689e2597------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 23:30:23 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@scbarrett/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Three crucial lessons for the wearables era]]></title>
            <link>https://medium.com/@scbarrett/three-crucial-lessons-for-the-wearables-era-59a038ae6d7a?source=rss-462a689e2597------2</link>
            <guid isPermaLink="false">https://medium.com/p/59a038ae6d7a</guid>
            <category><![CDATA[hardware]]></category>
            <category><![CDATA[tech]]></category>
            <category><![CDATA[apple]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[wearables]]></category>
            <dc:creator><![CDATA[Sam Barrett]]></dc:creator>
            <pubDate>Thu, 01 Jun 2017 03:53:44 GMT</pubDate>
            <atom:updated>2017-06-01T03:53:44.836Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Jdgnvm-cOi-JuDU6XD34yA.png" /><figcaption><a href="https://www.spectacles.com/images/structured-data/product.jpg">Snap Spectacles, Snap</a></figcaption></figure><p>The smartphone market is maturing— according to <a href="http://www.kpcb.com/internet-trends">Mary Meeker’s 2017 Internet Trends report</a>, global smartphone shipments were up only 3% in 2016 versus 10% from the year before. Apple also recently reported a 1% YoY decrease in iPhone sales in 2016, compared with the consistent 20%+ increases in sales the company hit from 2010–2014.</p><p>This is obviously not the end of the line for the smartphone; it will continue to be the single most important consumer technology product for the foreseeable future. In particular, there’s a lot of interesting developments on the horizon for 2017 — Apple in particular seems poised to have a strong year with the iPhone 8 set for release this coming fall and it’s likely that Andy Rubin’s new Essential Phone will continue to create buzz.</p><p>But the years of 40% YoY aggregate growth in smartphone sales are over. Instead, the industry has started to approach stasis — there will be modest growth in the install base driven by increase penetration abroad while a large portion of domestic sales will be driven by a replacement cycle that keeps getting longer.</p><p>So where will the next growth area in mobile computing be then? The consensus seems to be on wearables. From Snap’s Spectacles to Apple’s Airpods, incumbent players are focused on a future where smartphone capabilities are accessible one layer closer to the customer.</p><p>Startups, too, are experimenting with use cases to build wearable products that create a compelling use case for the mass market. To be sure, 2016 was the largest year ever for funding wearable companies, <a href="https://www.cbinsights.com/blog/wearables-funding-startups-q3-2016/">with a little less than $2B in committed capital recorded by CB Insights across that period</a>. Crowdfunding platforms such as Kickstarter and Indiegogo have also provided ample sources of startup capital for wearables, with success stories such as Pebble and Misfit financing their initial inventory run primarily through the platform.</p><p>I’m incredibly excited about all these developments — I truly believe these companies are helping to build a new mobile computing platform that has the potential to dramatically change how we technology influences our lives.</p><p>However, I think it’s important to understand that the wearable era won’t necessarily follow the same playbook as the development of the smartphone. In particular, there are a few key lessons that entrepreneurs in the space should internalize as they prototype, iterate, and grow:</p><ol><li><strong>Hardware is Hard:</strong> It’s one thing to prototype a wearable or to finance an initial run on Kickstarter; it’s quite another to produce a hit physical product for the mass market. Getting hundreds of thousands of products into the hands of consumers requires significant operational complexity, and will likely take 6–12 months to get to market. If you’re a wearables startup, having supply chain expertise on your team from day one is essential or you risk waitlists/stockouts that will diminish your brand equity just as your product is getting off the ground.</li><li><strong>Hardware Has a Monetization Lag:</strong> Once you’ve produced your product, you’ll be sitting on mountains of inventory that you’ll have to sell as quickly as possible. At the same time, you also need to start think about reinvesting the profits coming in to begin another product development process for your follow up product — or you’ll be stuck with rapidly declining revenues when your initial product matures and you don’t have another follow up ready to go. Any major hiccups in development timelines or consumer adoption of your first product can complicate this process further and even jeopardize your company. This monetization lag explains why hardware/wearable companies need to raise more capital than traditional software businesses.</li><li><strong>Hardware Products Don’t Retain Users Well: </strong>Your wearable needs to have a well defined use case that will keep users engaged. Even Apple messed up here with their first Apple Watch, and only recently corrected its mistake by pivoting toward the fitness market. Opening a smartphone app is incredibly simple compared with putting on a wearable every single day; focus on giving your customer a clear reason to continue to use the product month after month. If you don’t, you’ll likely lose those customers forever. Fitbit’s recent troubles as a public company are at least partially attributed to this lack of stickiness — once the initial thrill of counting steps faded and was eventually commoditized by smartphones, what good were these products anyway? Consumers will try anything once if the price point makes sense, but it’s incredibly difficult to convince them to be repeat customers if they bought your first generation product and churned from daily usage.</li></ol><p>Make no mistake, this is going to be a difficult industry for upstart players to conquer — the big companies in the space are already active, and there are significant capital, product development, and retention issues endemic to the industry. But the upside for companies that overcome these barriers and bring a truly differentiated product to market is enormous.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=59a038ae6d7a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[When will technology finally transform the US healthcare system?]]></title>
            <link>https://medium.com/@scbarrett/when-will-technology-finally-transform-the-us-healthcare-system-841927d4aa74?source=rss-462a689e2597------2</link>
            <guid isPermaLink="false">https://medium.com/p/841927d4aa74</guid>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[digital-health]]></category>
            <dc:creator><![CDATA[Sam Barrett]]></dc:creator>
            <pubDate>Wed, 24 May 2017 19:35:50 GMT</pubDate>
            <atom:updated>2017-05-24T19:35:50.172Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1PRFbUYHdzhFRCGujpU9jg.png" /><figcaption>Investors: Dumb Money For Digital Health Will Vanish As Quickly As It Came InChristina Farr — <a href="https://www.fastcompany.com/3057341/investors-dumb-money-for-digital-health-will-vanish-as-quickly-as-it-came-in">https://www.fastcompany.com/3057341/investors-dumb-money-for-digital-health-will-vanish-as-quickly-as-it-came-in</a></figcaption></figure><p>Healthcare has remained stubbornly immune to digitization. In fact, Bob Kocher from Venrock once referred to the industry as <a href="https://hbr.org/2014/12/why-so-many-tech-companies-are-getting-into-health-care">“the entrepreneurial equivalent of Siberia.”</a></p><p>Ten years ago, however, it seemed as though this perception was shifting. In particular, the HITECH Act of 2009 and the Affordable Care Act of 2010 created a real impetus to push the industry toward a digital future and value based care.</p><p>Yet despite these major policy initiatives having been in place for over a decade (and the ACA surviving several near death judicial/legislative scares), the revolution in healthcare technology has not yet come to pass — the industry has remained stubbornly antiquated. Major computational innovations that have revolutionized consumer technology in the past few years are almost completely absent from the American Healthcare System.</p><p>There remain some notable exceptions — on the private markets, companies like Zocdoc and Oscar are fundamentally reimagining some of the broken aspects of the American care experience, while public companies like Evolent Health have successfully partnered with providers to lead the charge toward value based care.</p><p>But given that the US healthcare industry alone accounts for roughly 20% of domestic GDP and digital health startups received over <a href="https://rockhealth.com/reports/2016-year-end-funding-report-a-reality-check-for-digital-health/">$6B in disclosed funding in 2016</a>, it’s shocking that we only have these select few success stories to point to.</p><p>I would argue that new digital health companies need to think bigger if they want to truly transform our broken healthcare system.</p><p><strong>Future Prospects: Truly Scalable Opportunities in Healthcare</strong></p><p>With that in mind, I believe there are several opportunities for healthcare investors and entrepreneurs to create truly scalable companies in the space. Those opportunities cluster into a few distinct areas — consumer choice, care management, and clinical decision making. Each represents a part of the system where there is massive inefficiency, and a true opportunity to use technology to help reshape the value chain of care.</p><p><strong><em>Opportunity 1: Empowering Consumer Choice</em></strong></p><p>Because of the rapid expansion of coverage under the ACA, a growing portion (37%) of non-elderly Americans are now under high deductible health insurance plans. Essentially, these plans are meant to only cover “catastrophic” healthcare events; they are not meant for routine expenses. Financially, that means consumers pay lower premiums but have much higher out of pocket costs up to a maximum out of pocket expenditure limit (up for $6500 for an individual, and $13,000 for a family).</p><p>This shift in payer dynamics fundamentally realigns consumer interests within the healthcare system. Under a typical health insurance plan, consumers have no incentive to monitor their own expenditures as even the first dollar of their care is covered by their health insurance company. However, under this new model, consumer interests are suddenly aligned with the payer, creating a strong incentive for individuals to control and limit their own utilization of healthcare services.</p><p>This patient empowerment will create opportunities for software companies to target this market, and will allay the issues that typically plague consumer-facing healthcare startups such as customer acquisition costs and churn. All across the healthcare value chain, these consumers will need help comparing insurance plans and self-directing their path through a wildly complex healthcare system in a way that will reduce their out of pocket costs. This is why software companies that aggregate data and serve as customer’s guides through the oftentimes-impenetrable American health system will stand to benefit from this shift.</p><p>At the same time, providers and payers will need more efficient and scalable ways to communicate with patients about how they receive and pay for care. The team over at <a href="https://angel.co/cedar-1">Cedar</a> looks like they’re doing interesting things around in this space around revenue cycle management — I’m curious what their product will look like once it’s out of stealth mode.</p><p><strong><em>Opportunity 2: Scalable Chronic Care Management</em></strong></p><p>The explosion of overall healthcare costs in the system has been driven by the increasing preponderance of chronic diseases in the US — nearly half of US adults have a chronic disease, and <a href="https://www.cdc.gov/chronicdisease/overview/">these diseases account for roughly 86% of overall healthcare spending in the US</a>. There’s no silver bullet to take care of these diseases; they’re influenced just as much by individual behavior as they are by biology.</p><p>As a result, there’s significant opportunities in the market for companies that can automate critical health tasks that help manage chronic diseases in a scalable way. Technology provides a key advantage here — it will allow companies to collect data, personalize treatments, keep in touch with patients via telehealth, predict potential care issues, and monitor adherence through mobile devices or customized hardware. Companies such as <a href="https://www.omadahealth.com/">Omada</a> have already made significant strides here by targeting disease verticals that are particularly costly for the healthcare system. The next step will be measuring improvements in patient health in order to prove efficacy of their products.</p><p>Truly scalable companies in this space should concentrate on eventually managing the risk/reward of outcomes. Bundled payment systems rolled out via the ACA provide incentive for companies that can offer solutions in a less costly way than the status quo; once these companies own the reimbursement side of the equation, the upside in terms of revenue potential is massive. A company that figures out how to own outcomes in a particularly large disease category could reach a scale not yet seen by digital health startups.</p><p><strong><em>Opportunity 3: Enhancing Clinical Decision-Making</em></strong></p><p>Another driver of the rapid increase in healthcare spending in the US across the last 20 years has been a decline in labor productivity. Over 56% of the $2.6 trillion spent on healthcare per year is for labor costs, <a href="http://www.nejm.org/doi/full/10.1056/NEJMp1109649.">and labor productivity as defined by output per working has not increased at all for healthcare workers in the past 20 years (even as all other sectors became more productive).</a></p><p>Technology (particularly SaaS products sold to providers) can potentially address this stagnation. For doctors, technology can improve decision-making by integrating the dispersed systems and data sets that feed care decisions — for example, by flagging rising risk patients in each care setting or by outsourcing critical care decisions such as radiology to AI. For hospital administrators, technology can drive labor management, allowing managers to better plan labor allocation. Across all stakeholders, the goal is to equip frontline workers with the tools, data, and interventions they need to do their jobs more efficiently. Early on, these tools could help reduce waste; eventually, they could direct a strategic reorganization of the way healthcare is delivered on a macro level.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=841927d4aa74" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The incredible venture deal that (almost) nobody seems to have heard of]]></title>
            <link>https://medium.com/@scbarrett/the-greatest-vc-deal-almost-no-one-has-heard-of-286d0ce7a5f8?source=rss-462a689e2597------2</link>
            <guid isPermaLink="false">https://medium.com/p/286d0ce7a5f8</guid>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[china]]></category>
            <category><![CDATA[finance]]></category>
            <category><![CDATA[technology]]></category>
            <dc:creator><![CDATA[Sam Barrett]]></dc:creator>
            <pubDate>Wed, 17 May 2017 21:12:42 GMT</pubDate>
            <atom:updated>2017-05-24T19:36:22.834Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vD7RKUAm_dWKpwjPfbm9Ug.png" /><figcaption>VenturePulse — Mar. 27 | Startups with the best Venture Investment Returns of All Time <a href="http://blog.venturepulse.org/issue-mar-27-startups-with-the-best-venture-investment-returns-of-all-time/">http://blog.venturepulse.org/issue-mar-27-startups-with-the-best-venture-investment-returns-of-all-time/</a></figcaption></figure><p>If I were to ask you to name the best venture deal of all time in terms of pure cash on cash return, what would you come back with?</p><p>My bet would be you’d answer with the usual suspects: Accel’s 2005 investment in Facebook, KPCB’s deal for Google, or maybe Lightspeed’s more recent, highly lucrative bet on Snapchat. Those deals are now legendary in the Valley, and for good reason — they eventually returned their initial investment hundreds of times over (see below).</p><p>Yet one deal dwarfs them all, and it still somehow seems to float under the radar.</p><p>I’m referring to the South African media conglomerate Naspers and its investment in Tencent. In 2001, years before Silicon Valley’s eyes had turned to China, Naspers paid $31M for a roughly 47% stake in Tencent, which was then a scrappy instant messaging startup; Tencent is of course now one of the most influential tech companies in the world and that stake is currently worth over $60B. That means Naspers has realized a nearly 2000x+ return on its initial investment.</p><p>In other words, the bet Naspers took on Tencent has turned out to be one of the most successful venture deals in history.</p><p>Why isn’t this story written in the venture capital history books like the other bets above?</p><p>Part of the answer likely comes down to geographic myopia — it’s natural for the VCs to remember successes from products built in their hometowns that they know well and likely use. It’s quite another to get excited about a corporate venture investment from a South African publisher in a nascent Chinese social network.</p><p>But for me, this insular mindset is a warning sign for smart investors — as we clamor to find the next white space within early stage technology, we’d do well to remember that it’s a big world out there.</p><p>Naspers has certainly internalized that lesson. With its stake in Tencent as a driver, it can invest much more aggressively than its core financials would typically allow, giving it the ammunition it needs to enter make corporate venture investments in potential “winner takes all” verticals in these emerging markets. Several early investments have been positive: it owns a sizable stake in Flipkart, which some are tapping to replicate the Alibaba model in India, and also invested in the Russian internet portal Mail.ru.</p><p>Will they find another opportunity on the scale of Tencent? Probably not, but they’ve seen first hand that the search can be worth the effort.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=286d0ce7a5f8" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>